Recently, high-throughput sequencing of breast and ovarian tumours revealed that common oncogene amplifications (i.e. CCND1 encoding cyclin D1 in breast cancer and CCNE1 encoding cyclin E in ovarian cancer) rarely occur in tumours with BRCA1/2 gene mutations18–20. This evidence concerns the gene CCNE1 and ovarian cancer.